China’s Renji Hospital launches IVF service app

It combines third-party assured data verification with blockchain technology.

China-based Renji Hospital, which is affiliated with the Shanghai Jiaotong University School of Medicine, has launched MyBaby, the world's first blockchain-based in-vitro fertilization (IVF) service application, according to a press release.

MyBaby enables the verification of key steps of IVF and provides private, exclusive, end-to-end data access for prospective parents undergoing treatment. It is the first service of its kind to combine third-party assured data verification with blockchain technology.

All information, imagery and data trails, from imagery produced by medical tools to the delivery of the zygote itself will be securely uploaded on the blockchain and only accessible to authorized users of the MyBaby Application, a statement revealed.

MyBaby allows users to view and track the extraction, labeling and scoring of fertilized eggs as well as the cultivation and preservation of embryos. The application also aims to solve the traditional problems associated with the privacy of sensitive medical data.